← Back to Search

Electronic Cigarette for Tobacco Use

N/A
Waitlist Available
Led By Nicholas Felicione, PhD
Research Sponsored by Roswell Park Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights

Study Summary

This trial is to see if non-tobacco oral nicotine products are appealing to cigarette smokers, smokeless tobacco users, and oral nicotine users.

Eligible Conditions
  • Tobacco Use
  • Tobacco Smoking
  • Smoking/Cigarette Smoking
  • Smokeless Tobacco Cessation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in nicotine boost
Change in sensory response
Secondary outcome measures
Change is stress markers

Trial Design

2Treatment groups
Experimental Treatment
Group I: Order 2 - Electronic Cigarettes and Oral Nicotine productExperimental Treatment2 Interventions
Participants will use each prodcut for up to 30 minutes but will also be permitted to stop use before the end of the 30-minute ad lib use period
Group II: Order 1 - Oral Nicotine product - ZYN and Electronic CigarettesExperimental Treatment2 Interventions
Participants will use each product for up to a 30 minute interval But will also be permitted to stop use before the end of the 30-minute ad lib use period

Find a Location

Who is running the clinical trial?

Roswell Park Cancer InstituteLead Sponsor
402 Previous Clinical Trials
30,843 Total Patients Enrolled
Nicholas Felicione, PhDPrincipal InvestigatorRoswell Park Comprehensive Cancer Center
Maciej Goniewicz, PhDPrincipal InvestigatorRoswell Park Comprehensive Cancer Center
1 Previous Clinical Trials
216 Total Patients Enrolled

Media Library

Electronic Cigarette Clinical Trial Eligibility Overview. Trial Name: NCT05030194 — N/A
Tobacco Use Research Study Groups: Order 1 - Oral Nicotine product - ZYN and Electronic Cigarettes, Order 2 - Electronic Cigarettes and Oral Nicotine product
Tobacco Use Clinical Trial 2023: Electronic Cigarette Highlights & Side Effects. Trial Name: NCT05030194 — N/A
Electronic Cigarette 2023 Treatment Timeline for Medical Study. Trial Name: NCT05030194 — N/A
Tobacco Use Patient Testimony for trial: Trial Name: NCT05030194 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Would I be a viable candidate for this research project?

"This medical experiment is seeking 40 participants between the ages of 21 and 55 who have a history of smoking cigarettes or consuming smokeless tobacco. Specifically, they must be 5+ cigarettes/day for 1 year OR consume at least five units per day for one year; portioned moist snuff, loose moist snuff, and nicotine patches are also allowed. To confirm their eligibility to partake in this study, candidates will need to demonstrate an understanding of its investigative nature by signing an approved written informed consent form prior to receiving any related products as well as adhere to a period of 8-10 hours (overnight) abstinence from using these substances which can"

Answered by AI

Are researchers actively seeking participants for this research program?

"Confirmed. The information held on clinicaltrials.gov indicates that this research is actively seeking patients, with 40 participants required from one medical centre since its initial posting date of October 21 2021 and most recent edit on August 17 2022."

Answered by AI

What is the scope of enrollment for this clinical investigation?

"Indeed, the information available on clinicaltrials.gov alludes to this trial being open for enrolment. This study was first posted in October of 2021 and has since been modified as recenty as August 2022. A total of 40 participants are required from one single medical facility."

Answered by AI

Are individuals below the age of fifty-five admissible for this research?

"This clinical trial is exclusively available to those aged 21 and above, but younger than 55."

Answered by AI

Who else is applying?

What state do they live in?
Massachusetts
Minnesota
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
2

Why did patients apply to this trial?

I tried to quit smoking for a long time and will be 50 years old next month and I would a change of thinking based on all natural health and need support in anyway.
PatientReceived no prior treatments
~4 spots leftby Apr 2025